Drugs / VRC-FLUDNA057-00-VP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00973895 | Aug 2009 → Sep 2010 | swine influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-FLUDNA057-00-VP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00973895 ↗ |
| Modality | Vaccine | “investigational plasmid DNA vaccine” NCT00973895 ↗ |
| Route | Intramuscular | “Vaccinations with the H1 DNA vaccine will be administered intramuscularly (IM) in the deltoid muscle” NCT00973895 ↗ |